T1	PROC 1 20	Estudio comparativo
#1	AnnotatorNotes T1	C1579762; comparative study research; Research Activity
T2	PROC 56 78	tratamiento prolongado
T3	CHEM 83 93	esteroides
#2	AnnotatorNotes T3	C0038317; Steroids; Organic Chemical · Pharmacologic Substance
T4	DISO 100 135	síndrome nefrótico cortico-sensible
#3	AnnotatorNotes T4	C0403396; Steroid-sensitive nephrotic syndrome; Disease or Syndrome
T5	DISO 217 221	SNCS
#4	AnnotatorNotes T5	C0403396; Steroid-sensitive nephrotic syndrome; Disease or Syndrome
T6	DISO 180 215	síndrome nefrótico cortico-sensible
#5	AnnotatorNotes T6	C0403396; Steroid-sensitive nephrotic syndrome; Disease or Syndrome
T7	PROC 227 252	corticoterapia prolongada
T8	CHEM 356 366	corticoide
#6	AnnotatorNotes T8	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T9	PROC 388 399	tratamiento
#7	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T10	PROC 574 585	tratamiento
#8	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T11	CHEM 782 802	16-β-metilprednisona
T12	CHEM 655 671	corticosteroides
#9	AnnotatorNotes T12	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T13	DISO 677 686	toxicidad
#10	AnnotatorNotes T13	C0600688; Toxic effect; Injury or Poisoning
T14	CHEM 687 696	esteroide
#11	AnnotatorNotes T14	C0038317; Steroids; Organic Chemical · Pharmacologic Substance
T15	CHEM 899 919	16-β-metilprednisona
T16	PROC 942 949	placebo
#12	AnnotatorNotes T16	C0032042; Placebos; Therapeutic or Preventive Procedure
T17	PROC 1270 1281	tratamiento
#13	AnnotatorNotes T17	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T18	PROC 30 50	esquema convencional
T19	CHEM 1628 1636	cortisol
#14	AnnotatorNotes T19	C0020268; hydrocortisone; Organic Chemical · Pharmacologic Substance · Hormone
T20	ANAT 1637 1643	sérico
#15	AnnotatorNotes T20	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T21	DISO 1715 1724	toxicidad
#16	AnnotatorNotes T21	C0600688; Toxic effect; Injury or Poisoning
T22	CHEM 1725 1734	esteroide
#17	AnnotatorNotes T22	C0038317; Steroids; Organic Chemical · Pharmacologic Substance
T23	PROC 1799 1810	tratamiento
#18	AnnotatorNotes T23	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T24	DISO 1863 1872	toxicidad
#19	AnnotatorNotes T24	C0600688; Toxic effect; Injury or Poisoning
T25	CHEM 1873 1882	esteroide
#20	AnnotatorNotes T25	C0038317; Steroids; Organic Chemical · Pharmacologic Substance
T26	PROC 1628 1643	cortisol sérico
#21	AnnotatorNotes T26	C1254867; Serum Hydrocortisone Test; Laboratory Procedure
T27	PROC 348 377	esquema corticoide prolongado
T28	DISO 413 417	SNCS
#22	AnnotatorNotes T28	C0403396; Steroid-sensitive nephrotic syndrome; Disease or Syndrome
T29	LIVB 478 487	pacientes
#23	AnnotatorNotes T29	C0030705; Patients; Patient or Disabled Group
T30	LIVB 763 772	pacientes
#24	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group
T31	Duration 811 821	12 semanas
T32	Date 849 861	la semana 24
T33	LIVB 880 889	pacientes
#25	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	Duration 928 938	12 semanas
T35	Date 956 968	la semana 24
T36	LIVB 1029 1036	persona
#26	AnnotatorNotes T36	C0027361; Persons; Population Group
T38	LIVB 1446 1455	pacientes
#27	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T40	LIVB 1551 1559	paciente
#28	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T42	LIVB 712 721	población
#29	AnnotatorNotes T42	C1257890; Population; Population Group
T43	PROC 823 842	reduciendo la dosis
#30	AnnotatorNotes T43	C2348004; Agent Dose Decreased; Therapeutic or Preventive Procedure
T44	Duration 1171 1174	114
#31	AnnotatorNotes T44	[Duration expressed in days]
T45	Duration 1191 1193	75
#32	AnnotatorNotes T45	[Duration expressed in days]
T37	Dose 1567 1572	5,243
#33	AnnotatorNotes T37	[Dose expressed in mg/m2]
T46	Dose 1592 1597	4,306
#34	AnnotatorNotes T46	[Dose expressed in mg/m2]
T39	DISO 285 293	recaídas
#35	AnnotatorNotes T39	C2825055; Recurrence (disease attribute); Pathologic Function
T41	DISO 492 500	recaídas
#36	AnnotatorNotes T41	C2825055; Recurrence (disease attribute); Pathologic Function
T47	DISO 521 529	recaídas
#37	AnnotatorNotes T47	C2825055; Recurrence (disease attribute); Pathologic Function
T48	DISO 624 631	recaída
#38	AnnotatorNotes T48	C2825055; Recurrence (disease attribute); Pathologic Function
T49	DISO 1019 1027	recaídas
#39	AnnotatorNotes T49	C2825055; Recurrence (disease attribute); Pathologic Function
T50	DISO 1156 1163	recaída
#40	AnnotatorNotes T50	C2825055; Recurrence (disease attribute); Pathologic Function
T51	DISO 1460 1468	recaídas
#41	AnnotatorNotes T51	C2825055; Recurrence (disease attribute); Pathologic Function
T52	DISO 1369 1377	recaídas
#42	AnnotatorNotes T52	C2825055; Recurrence (disease attribute); Pathologic Function
T53	DISO 1834 1842	recaídas
#43	AnnotatorNotes T53	C2825055; Recurrence (disease attribute); Pathologic Function
T54	Neg_cue 1321 1323	no
T55	Quantifier_or_Qualifier 1331 1345	significativas
A1	Assertion T55 Negated
#44	AnnotatorNotes T55	C0750502; Significant; Idea or Concept
R1	Negation Arg1:T54 Arg2:T55	
T56	Neg_cue 1844 1847	sin
T57	CONC 1848 1859	incrementar
A2	Assertion T57 Negated
#45	AnnotatorNotes T57	C0442805; Increase; Functional Concept
R2	Negation Arg1:T56 Arg2:T57	
T58	Spec_cue 253 259	podría
T59	CONC 260 267	reducir
A3	Assertion T59 Speculated
R3	Speculation Arg1:T58 Arg2:T59	
R4	Used_for Arg1:T3 Arg2:T2	
T60	Quantifier_or_Qualifier 136 144	primario
#46	AnnotatorNotes T60	C0205225; Primary; Qualitative Concept
R5	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T60	
R11	Before Arg1:T5 Arg2:T39	
R12	Before Arg1:T6 Arg2:T39	
R13	Used_for Arg1:T8 Arg2:T27	
T61	Quantifier_or_Qualifier 418 426	primario
#47	AnnotatorNotes T61	C0205225; Primary; Qualitative Concept
R14	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T61	
R17	Experiences Arg1:T29 Arg2:T27	
R18	Experiences Arg1:T29 Arg2:T9	
R19	Experiences Arg1:T29 Arg2:T28	
R20	Experiences Arg1:T29 Arg2:T41	
R21	Before Arg1:T28 Arg2:T41	
R22	Before Arg1:T28 Arg2:T47	
R23	Experiences Arg1:T29 Arg2:T47	
R24	Experiences Arg1:T29 Arg2:T10	
R25	Experiences Arg1:T29 Arg2:T48	
R26	Experiences Arg1:T29 Arg2:T12	
R27	Experiences Arg1:T29 Arg2:T13	
R28	Experiences Arg1:T29 Arg2:T14	
R29	Causes Arg1:T14 Arg2:T13	
T62	CONC 636 651	dosis acumulada
#48	AnnotatorNotes T62	C2986497; Cumulative Dose; Conceptual Entity
R30	Has_Dose_or_Strength Arg1:T12 Arg2:T62	
T63	Quantifier_or_Qualifier 616 623	primera
#49	AnnotatorNotes T63	C0205435; First (number); Quantitative Concept  (?)
R31	Has_Quantifier_or_Qualifier Arg1:T48 Arg2:T63	
T64	Observation 596 604	remisión
#50	AnnotatorNotes T64	C0544452; Disease remission; Finding
R32	Experiences Arg1:T29 Arg2:T64	
R33	Before Arg1:T47 Arg2:T64	
R34	Before Arg1:T41 Arg2:T64	
R35	Before Arg1:T10 Arg2:T47	
R36	Before Arg1:T10 Arg2:T41	
T65	CONC 534 540	tiempo
#51	AnnotatorNotes T65	C0040223; Time; Temporal Concept
R37	Before Arg1:T10 Arg2:T48	
R38	Before Arg1:T28 Arg2:T48	
R39	Before Arg1:T28 Arg2:T10	
R40	Used_for Arg1:T12 Arg2:T10	
R41	Used_for Arg1:T14 Arg2:T10	
R42	Used_for Arg1:T12 Arg2:T9	
R43	Causes Arg1:T14 Arg2:T9	
R44	Experiences Arg1:T30 Arg2:T11	
R45	Has_Duration_or_Interval Arg1:T11 Arg2:T31	
R46	Used_for Arg1:T11 Arg2:T43	
#52	AnnotatorNotes T11	C0065967; meprednisone; Hormone · Organic Chemical · Pharmacologic Substance (?)
R47	Before Arg1:T43 Arg2:T32	
R48	Experiences Arg1:T33 Arg2:T15	
#53	AnnotatorNotes T15	C0065967; meprednisone; Hormone · Organic Chemical · Pharmacologic Substance (?)
R49	Has_Duration_or_Interval Arg1:T15 Arg2:T34	
R50	Experiences Arg1:T33 Arg2:T16	
R51	Before Arg1:T15 Arg2:T16	
R52	Before Arg1:T16 Arg2:T35	
R53	Experiences Arg1:T42 Arg2:T15	
R54	Experiences Arg1:T42 Arg2:T11	
R55	Experiences Arg1:T30 Arg2:T43	
T66	CONC 987 1015	tasa de incidencia acumulada
#54	AnnotatorNotes T66	C1708485; Incidence Rate; Temporal Concept + C0683920; Incidence Proportion; Quantitative Concept (?)
R56	Experiences Arg1:T36 Arg2:T49	
T67	CONC 1106 1112	tiempo
#55	AnnotatorNotes T67	C0040223; Time; Temporal Concept
R57	Has_Duration_or_Interval Arg1:T67 Arg2:T44	
R58	Has_Duration_or_Interval Arg1:T67 Arg2:T45	
R59	Overlap Arg1:T50 Arg2:T44	
R60	Overlap Arg1:T50 Arg2:T45	
T68	CONC 1224 1245	diferencias de tiempo
T69	Observation 1293 1301	remisión
#57	AnnotatorNotes T69	C0544452; Disease remission; Finding
R61	Before Arg1:T17 Arg2:T69	
T70	CONC 1350 1365	total acumulado
#58	AnnotatorNotes T70	C0683920; Incidence Proportion; Quantitative Concept (?)
R62	Experiences Arg1:T38 Arg2:T52	
R63	Experiences Arg1:T38 Arg2:T51	
T71	CONC 1517 1522;1529 1538	dosis acumulada
#59	AnnotatorNotes T71	C2986497; Cumulative Dose; Conceptual Entity
R64	Has_Dose_or_Strength Arg1:T71 Arg2:T37	
R65	Has_Dose_or_Strength Arg1:T71 Arg2:T46	
R66	Experiences Arg1:T40 Arg2:T26	
R67	Location_of Arg1:T20 Arg2:T26	
R68	Causes Arg1:T22 Arg2:T21	
R69	Before Arg1:T23 Arg2:T53	
R71	Causes Arg1:T25 Arg2:T24	
R72	Used_for Arg1:T25 Arg2:T23	
#61	AnnotatorNotes T59	C0547047; Decrease; Functional Concept 
R6	Before Arg1:T7 Arg2:T39	
R7	Has_Quantifier_or_Qualifier Arg1:T68 Arg2:T55	
#56	AnnotatorNotes T68	C1442103; Time Difference; Temporal Concept
T72	Quantifier_or_Qualifier 1652 1657	final
#60	AnnotatorNotes T72	C1517741; Last; Qualitative Concept
R8	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T72	
A4	Experiencer T38 Patient
A5	Experiencer T40 Patient
A6	Experiencer T36 Patient
A7	Experiencer T33 Patient
A8	Experiencer T30 Patient
A9	Experiencer T42 Patient
A10	Experiencer T29 Patient
